-- First Patient Dosed in University of Chicago Phase 2a Trial of EDP1503 in ...
MELBOURNE, Australia, July 31, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”) is pleased ...
Adjusted Vectra Test Is Up to Five Times More Effective for Predicting Radiographic Progression ...
